Literature DB >> 5833611

Tryptamine metabolism in depression.

A Coppen, D M Shaw, A Malleson, E Eccleston, G Gundy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5833611     DOI: 10.1192/bjp.111.479.993

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  23 in total

Review 1.  The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.

Authors:  Gregory M Miller
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

2.  5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illness.

Authors:  A Coppen; P Turner; A R Rowsell; C Padgham
Journal:  Postgrad Med J       Date:  1976-03       Impact factor: 2.401

Review 3.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

Review 4.  A unifying hypothesis on the biochemical basis of affective disorder.

Authors:  M M Singh
Journal:  Psychiatr Q       Date:  1970

5.  The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.

Authors:  P Riederer; W Birkmayer; E Neumayer; L Ambrozi; W Linauer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

6.  The tyrosine-tryptophan-diagram in a longtime study with depressed patients.

Authors:  P Riederer; W Birkmayer; E Neumayer
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

Review 7.  Accessing Bioactive Natural Products from the Human Microbiome.

Authors:  Aleksandr Milshteyn; Dominic A Colosimo; Sean F Brady
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

Review 8.  Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.

Authors:  Lee A Dawson; Jeannette M Watson
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

9.  Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan.

Authors:  A R Green; J K Aronson; G Curzon; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

Review 10.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.